126 related articles for article (PubMed ID: 22994738)
1. Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells.
Chen P; Wang XL; Ma ZS; Xu Z; Jia B; Ren J; Hu YX; Zhang QH; Ma TG; Yan BD; Yan QZ; Li YL; Li Z; Yu JY; Gao R; Fan N; Li B; Yang JL
Asian Pac J Cancer Prev; 2012; 13(7):3223-8. PubMed ID: 22994738
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
3. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.
Zhou X; Yuan B; Yuan W; Wang C; Gao R; Wang J
Tumour Biol; 2014 Jul; 35(7):6539-47. PubMed ID: 24687550
[TBL] [Abstract][Full Text] [Related]
4. The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.
Weng M; Song F; Chen J; Wu J; Qin J; Jin T; Xu J
Tumour Biol; 2015 Feb; 36(2):959-66. PubMed ID: 25315189
[TBL] [Abstract][Full Text] [Related]
5. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
[TBL] [Abstract][Full Text] [Related]
6. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
Liu X; Ma W; Yan Y; Wu S
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA targeting HMGN5 induces apoptosis via modulation of a mitochondrial pathway and Bcl-2 family proteins in prostate cancer cells.
Zhang XY; Guo ZQ; Ji SQ; Zhang M; Jiang N; Li XS; Zhou LQ
Asian J Androl; 2012 May; 14(3):487-92. PubMed ID: 22504871
[TBL] [Abstract][Full Text] [Related]
8. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
[TBL] [Abstract][Full Text] [Related]
9. Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.
Guo Z; Zhang X; Li X; Xie F; Su B; Zhang M; Zhou L
Oncol Rep; 2015 Mar; 33(3):1519-25. PubMed ID: 25572120
[TBL] [Abstract][Full Text] [Related]
10. HMGN5: a potential oncogene in gliomas.
Qu J; Yan R; Chen J; Xu T; Zhou J; Wang M; Chen C; Yan Y; Lu Y
J Neurooncol; 2011 Sep; 104(3):729-36. PubMed ID: 21373965
[TBL] [Abstract][Full Text] [Related]
11. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.
Jiang N; Zhou LQ; Zhang XY
Asian J Androl; 2010 Sep; 12(5):709-17. PubMed ID: 20531280
[TBL] [Abstract][Full Text] [Related]
13. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells.
Ma Q; Wang X; Wang H; Song W; Wang Q; Wang J
Biomed Res Int; 2020; 2020():8610271. PubMed ID: 32596388
[TBL] [Abstract][Full Text] [Related]
14. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
[TBL] [Abstract][Full Text] [Related]
15. Role of the CKIP1 gene in proliferation and apoptosis of the human lung cancer cell line H1299.
Chen GM; Ding RF; Tan YD; Pan XB; Jiang GM; He JF; Lin SH; Liu C; Jia Y
Genet Mol Res; 2015 Apr; 14(2):4005-14. PubMed ID: 25966172
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy.
Yang C; Gao R; Wang J; Yuan W; Wang C; Zhou X
Tumour Biol; 2014 Jul; 35(7):6357-63. PubMed ID: 24664583
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis.
Wang XM; Cui JW; Li W; Cai L; Song W; Wang GJ
Asian Pac J Cancer Prev; 2012; 13(3):1043-8. PubMed ID: 22631635
[TBL] [Abstract][Full Text] [Related]
18. HMGN5 expression in bladder cancer tissue and its role on prognosis.
Wu J; Wang J
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):970-975. PubMed ID: 29509244
[TBL] [Abstract][Full Text] [Related]
19. Research advances in HMGN5 and cancer.
Shi Z; Tang R; Wu D; Sun X
Tumour Biol; 2016 Feb; 37(2):1531-9. PubMed ID: 26700674
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
Ge L; Deng Z; Zhang Y; Shao W; Qiu Y; Cui D; Huang D
Oncol Rep; 2011 Dec; 26(6):1487-95. PubMed ID: 21922145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]